Andrea Schneider, Ph.D.
Assistant Research Scientist, Department of Pediatrics, School of Medicine, Fragile X Research & Treatment Center
UC Davis MIND Institute
2825 50th Street
Sacramento, CA 95817
From very early on in her academic career, Dr. Schneider focused on interdisciplinary research with brain-behavior interactions and acquired broad knowledge in clinical psychology and medical neuroscience, with specific training and expertise in ADHD, learning disabilities, and fragile X spectrum disorders. Being also a clinical psychologist, her other area of interest is intervention research. As a graduate student, she completed a pilot study of a phytopharmacological intervention (Ginkgo biloba) in dyslexia, and a study about the efficacy of neurofeedback in ADHD.
Currently, Dr. Schneider's main research interest is the association between genetic and brain abnormalities underlying the neuropsychopathology, behavioral, and psychiatric symptoms in individuals with the fragile X spectrum disorders and autism. Her major research approach focuses on a number of psychophysiological indicators, like electroencephalography / event-related potentials (EEG/ERP) measures in fragile X spectrum disorders and ASD, prepulse inhibition, eye tracking, and biofeedback. Dr. Schneider is strongly committed to understanding, prevention, care, and cure of neurodevelopmental disorders.
B.S., Psychology, University of Potsdam, Germany, 1997
M.S., Clinical & Educational Psychology, Minor Neurology, University of Potsdam, Germany, 2001
Ph.D., Psychology, Clinical Psychology and Psychotherapy, University of Potsdam, Germany, 2007